CN110755291A - Anti-inflammatory and bactericidal mouthwash - Google Patents
Anti-inflammatory and bactericidal mouthwash Download PDFInfo
- Publication number
- CN110755291A CN110755291A CN201810849545.8A CN201810849545A CN110755291A CN 110755291 A CN110755291 A CN 110755291A CN 201810849545 A CN201810849545 A CN 201810849545A CN 110755291 A CN110755291 A CN 110755291A
- Authority
- CN
- China
- Prior art keywords
- parts
- sodium
- inflammatory
- propylene glycol
- xylitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 16
- 239000002324 mouth wash Substances 0.000 title claims abstract description 15
- 229940051866 mouthwash Drugs 0.000 title claims abstract description 14
- 230000000922 anti-bactericidal effect Effects 0.000 title claims abstract description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 57
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 51
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims abstract description 36
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 18
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 18
- 239000011775 sodium fluoride Substances 0.000 claims abstract description 18
- 235000013024 sodium fluoride Nutrition 0.000 claims abstract description 18
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 17
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 17
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000008367 deionised water Substances 0.000 claims abstract description 17
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 17
- 229940041616 menthol Drugs 0.000 claims abstract description 17
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 17
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims abstract description 17
- 235000010234 sodium benzoate Nutrition 0.000 claims abstract description 17
- 239000004299 sodium benzoate Substances 0.000 claims abstract description 17
- 239000001509 sodium citrate Substances 0.000 claims abstract description 17
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000811 xylitol Substances 0.000 claims abstract description 17
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 17
- 229960002675 xylitol Drugs 0.000 claims abstract description 17
- 235000010447 xylitol Nutrition 0.000 claims abstract description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 7
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000015165 citric acid Nutrition 0.000 claims abstract description 7
- 235000013772 propylene glycol Nutrition 0.000 claims abstract description 7
- 235000011083 sodium citrates Nutrition 0.000 claims abstract description 7
- LWXGQYPEQACKRT-UHFFFAOYSA-N [Cl-].[NH4+].[As] Chemical compound [Cl-].[NH4+].[As] LWXGQYPEQACKRT-UHFFFAOYSA-N 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 10
- 210000000214 mouth Anatomy 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000003467 diminishing effect Effects 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000000740 bleeding effect Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 5
- 210000003298 dental enamel Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses anti-inflammatory and bactericidal mouthwash. The invention consists of dipotassium glycyrrhizinate, sodium benzoate, ammonium arsenicum, xylitol, propylene glycol, sodium fluoride, sodium citrate, citric acid, menthol and deionized water; the anti-inflammatory mouth wash does not contain ethanol, can clean oral cavity, eliminate peculiar smell of the oral cavity and refresh breath, has the effects of diminishing inflammation, easing pain, relieving swelling and pain of gum and bleeding gum and effectively prevents decayed teeth.
Description
Technical Field
The invention relates to a mouthwash, in particular to an anti-inflammatory and bactericidal mouthwash.
Background
Mouthwash is one type of oral hygiene product. The main component is sodium fluoride. The fluoride reacts with the enamel to form fluorapatite on the surface of the enamel, thereby improving the hardness and acid resistance of the enamel, reducing the formation of dental plaque and the incidence rate of dental caries, and being helpful to keep the oral hygiene by properly using mouthwash. However, at present, many mouthwashes contain ethanol which is volatile and has large irritation to oral mucosa and certain damage.
Disclosure of Invention
The invention aims to provide the anti-inflammatory and bactericidal mouthwash aiming at the defects of the prior art; the oral cavity cleaning liquid does not contain ethanol, can clean the oral cavity, eliminate the peculiar smell of the oral cavity and refresh breath, has the effects of diminishing inflammation, easing pain, relieving swelling and pain of gum and bleeding gum, and effectively prevents decayed teeth.
The technical scheme adopted by the invention is as follows:
an anti-inflammatory and bactericidal oral liquid is characterized in that: is prepared from dipotassium glycyrrhizinate, sodium benzoate, ammonium arsenicum, xylitol, propylene glycol, sodium fluoride, sodium citrate, citric acid, menthol and deionized water;
3-11 parts of dipotassium glycyrrhizinate;
3-7 parts of sodium benzoate;
5-10 parts of arsenic ammonium chloride;
5-15 parts of xylitol;
5-15 parts of propylene glycol;
2-6 parts of sodium fluoride;
2-4 parts of sodium citrate;
1-3 parts of citric acid;
2-6 parts of menthol;
20-40 parts of deionized water;
the parts are parts by weight.
The preferred scheme of the invention is as follows:
5 parts of dipotassium glycyrrhizinate;
4 parts of sodium benzoate;
7 parts of arsenic ammonium chloride;
9 parts of xylitol;
the propylene glycol accounts for 8 parts;
3 parts of sodium fluoride;
the sodium citrate is 2 parts;
1 part of citric acid;
the menthol accounts for 3 parts;
28 parts of deionized water;
the parts are parts by weight.
The other preferable scheme of the invention is as follows:
9 parts of dipotassium glycyrrhizinate;
8 parts of sodium benzoate;
8 parts of arsenic ammonium chloride;
10 parts of xylitol;
9 parts of propylene glycol;
the sodium fluoride accounts for 5 parts;
4 parts of sodium citrate;
3 parts of citric acid;
5 parts of menthol;
35 parts of deionized water;
the parts are parts by weight.
The invention is prepared according to the conventional technical method.
The invention has the following advantages:
compared with the prior art, the invention has the following beneficial technical effects:
1. the anti-inflammatory and bactericidal mouthwash does not contain ethanol, propylene glycol is used for replacing the ethanol, the propylene glycol is not easy to volatilize, the nature is mild, and the mouthwash is non-toxic and cannot stimulate oral mucosa; the arsenic ammonium chloride is added, so that the formation of dental plaque can be reduced or inhibited, the growth and reproduction of bacteria can be inhibited, and the effects of sterilizing and inhibiting bacteria, keeping the oral cavity clean and removing the oral cavity peculiar smell are achieved; the added dipotassium glycyrrhizinate has the effects of bacteriostasis, inflammation diminishing, detoxification, anti-allergy, deodorization and the like.
2. The anti-inflammatory and antibacterial mouth wash disclosed by the invention can clean the oral cavity, eliminate peculiar smell in the oral cavity and refresh breath, has the effects of diminishing inflammation, easing pain, relieving swelling and pain of gum and bleeding gum and effectively prevents decayed teeth.
Detailed Description
Example 1
An anti-inflammatory and bactericidal oral liquid is characterized in that: is prepared from dipotassium glycyrrhizinate, sodium benzoate, ammonium arsenicum, xylitol, propylene glycol, sodium fluoride, sodium citrate, citric acid, menthol and deionized water;
3 parts of dipotassium glycyrrhizinate;
the sodium benzoate is 3 parts;
5 parts of arsenic ammonium chloride;
the xylitol accounts for 5 parts;
the propylene glycol accounts for 5 parts;
the sodium fluoride accounts for 2 parts;
the sodium citrate is 2 parts;
1 part of citric acid;
the menthol accounts for 2 parts;
20 parts of deionized water;
the parts are parts by weight.
The invention is prepared according to the conventional technical method.
Example 2
An anti-inflammatory and bactericidal oral liquid is characterized in that: is prepared from dipotassium glycyrrhizinate, sodium benzoate, ammonium arsenicum, xylitol, propylene glycol, sodium fluoride, sodium citrate, citric acid, menthol and deionized water;
5 parts of dipotassium glycyrrhizinate;
4 parts of sodium benzoate;
7 parts of arsenic ammonium chloride;
9 parts of xylitol;
the propylene glycol accounts for 8 parts;
3 parts of sodium fluoride;
the sodium citrate is 2 parts;
1 part of citric acid;
the menthol accounts for 3 parts;
28 parts of deionized water;
the parts are parts by weight.
The parts are parts by weight.
The invention is prepared according to the conventional technical method.
Example 3
An anti-inflammatory and bactericidal oral liquid is characterized in that: is prepared from dipotassium glycyrrhizinate, sodium benzoate, ammonium arsenicum, xylitol, propylene glycol, sodium fluoride, sodium citrate, citric acid, menthol and deionized water;
9 parts of dipotassium glycyrrhizinate;
8 parts of sodium benzoate;
8 parts of arsenic ammonium chloride;
10 parts of xylitol;
9 parts of propylene glycol;
the sodium fluoride accounts for 5 parts;
4 parts of sodium citrate;
3 parts of citric acid;
5 parts of menthol;
35 parts of deionized water;
the parts are parts by weight.
The parts are parts by weight.
The invention is prepared according to the conventional technical method.
Example 4
An anti-inflammatory and bactericidal oral liquid is characterized in that: is prepared from dipotassium glycyrrhizinate, sodium benzoate, ammonium arsenicum, xylitol, propylene glycol, sodium fluoride, sodium citrate, citric acid, menthol and deionized water;
11 parts of dipotassium glycyrrhizinate;
7 parts of sodium benzoate;
10 parts of arsenic ammonium chloride;
15 parts of xylitol;
the propylene glycol accounts for 15 parts;
6 parts of sodium fluoride;
4 parts of sodium citrate;
3 parts of citric acid;
the menthol accounts for 6 parts;
40 parts of deionized water;
the parts are parts by weight.
The invention is prepared according to the conventional technical method.
Claims (3)
1. An anti-inflammatory and bactericidal oral liquid is characterized in that: is prepared from dipotassium glycyrrhizinate, sodium benzoate, ammonium arsenicum, xylitol, propylene glycol, sodium fluoride, sodium citrate, citric acid, menthol and deionized water;
3-11 parts of dipotassium glycyrrhizinate;
3-7 parts of sodium benzoate;
5-10 parts of arsenic ammonium chloride;
5-15 parts of xylitol;
5-15 parts of propylene glycol;
2-6 parts of sodium fluoride;
2-4 parts of sodium citrate;
1-3 parts of citric acid;
2-6 parts of menthol;
20-40 parts of deionized water;
the parts are parts by weight.
2. An anti-inflammatory and antibacterial mouthwash according to claim 1, wherein:
5 parts of dipotassium glycyrrhizinate;
4 parts of sodium benzoate;
7 parts of arsenic ammonium chloride;
9 parts of xylitol;
the propylene glycol accounts for 8 parts;
3 parts of sodium fluoride;
the sodium citrate is 2 parts;
1 part of citric acid;
the menthol accounts for 3 parts;
28 parts of deionized water;
the parts are parts by weight.
3. An anti-inflammatory and antibacterial mouthwash according to claim 1, wherein:
9 parts of dipotassium glycyrrhizinate;
8 parts of sodium benzoate;
8 parts of arsenic ammonium chloride;
10 parts of xylitol;
9 parts of propylene glycol;
the sodium fluoride accounts for 5 parts;
4 parts of sodium citrate;
3 parts of citric acid;
5 parts of menthol;
35 parts of deionized water;
the parts are parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810849545.8A CN110755291A (en) | 2018-07-28 | 2018-07-28 | Anti-inflammatory and bactericidal mouthwash |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810849545.8A CN110755291A (en) | 2018-07-28 | 2018-07-28 | Anti-inflammatory and bactericidal mouthwash |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110755291A true CN110755291A (en) | 2020-02-07 |
Family
ID=69328744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810849545.8A Pending CN110755291A (en) | 2018-07-28 | 2018-07-28 | Anti-inflammatory and bactericidal mouthwash |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110755291A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112245317A (en) * | 2020-09-07 | 2021-01-22 | 广州雨晓生物制品有限公司 | Mouthwash |
| CN113197786A (en) * | 2021-04-20 | 2021-08-03 | 苏州清馨健康科技有限公司 | Oral bacteriostatic composition, mouth wash composition, preparation method and application thereof |
| CN113576938A (en) * | 2021-08-26 | 2021-11-02 | 广东丸美生物技术股份有限公司 | Oral care composition and application thereof |
-
2018
- 2018-07-28 CN CN201810849545.8A patent/CN110755291A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112245317A (en) * | 2020-09-07 | 2021-01-22 | 广州雨晓生物制品有限公司 | Mouthwash |
| CN113197786A (en) * | 2021-04-20 | 2021-08-03 | 苏州清馨健康科技有限公司 | Oral bacteriostatic composition, mouth wash composition, preparation method and application thereof |
| CN113576938A (en) * | 2021-08-26 | 2021-11-02 | 广东丸美生物技术股份有限公司 | Oral care composition and application thereof |
| CN113576938B (en) * | 2021-08-26 | 2022-07-08 | 广东丸美生物技术股份有限公司 | Oral care composition and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018105782A (en) | COMPOSITIONS FOR CARE OF THE ORAL CAVITY AND METHODS OF USE | |
| CN106265423B (en) | Oral care composition with effects of clearing fire and relieving pain | |
| US4224307A (en) | Mouthwash and methods | |
| JP2005504109A5 (en) | ||
| JPS6183113A (en) | Oral composition | |
| RU2018144620A (en) | COMPOSITIONS FOR CARE OF THE ORAL CAVITY AND METHODS OF USE | |
| JPWO2016031461A1 (en) | Oral composition for alleviating dentine hypersensitivity | |
| RU2013126518A (en) | ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE | |
| CN108096047A (en) | Domiphen bromide xylitol combination of acidic mouthwash and preparation method thereof | |
| CN104288466B (en) | A kind of medical bio fluoride in caries prevention dressing and preparation method thereof | |
| KR20170052278A (en) | Oral composition for removal of biofilm | |
| CN104398438A (en) | Toothpaste for preventing ozostomia | |
| KR20160007049A (en) | Improved anti-inflammatory and germicidal composition for preventing or alleviating periodontal disease | |
| CN104042780A (en) | Oral cavity care solution | |
| CN113197786A (en) | Oral bacteriostatic composition, mouth wash composition, preparation method and application thereof | |
| CN108066166A (en) | Remove acid mouthwash of calculus dentalis and preparation method thereof | |
| CN106491389A (en) | A kind of shitosan tooth protection children's toothpaste | |
| JP2016124855A (en) | Oral hydrogel composition | |
| KR20160063814A (en) | Oral composition comprising fermented extract of blackberry and manufacturing method thereof | |
| KR20170037230A (en) | Oral composition comprising cassava extract | |
| CN106581677A (en) | Bacteriostatic spray for removing bad breath | |
| CN110755289A (en) | Children mouthwash | |
| CN114272191A (en) | Toothpaste for protecting gingiva and children and preparation method thereof | |
| CN113633574A (en) | Anti-caries mouthwash and preparation method thereof | |
| KR102090592B1 (en) | An oral composition for preventing dental calculus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200207 |